ERA-EDTA 58th ERA-EDTA Congress Symposia 2021
Format:413 videos, size: 168 GB
Course Audience: nephrologist
A Look In Tge Crystal Ball Environment & Education – A STEP TOWARD GREEN NEPHROLOGY APPLYING THE PASSIVE HOUSE (Video MP4 Format)
A Look In Tge Crystal Ball Environment & Education – Achieving sustainable development goals in nephrology care, research and education 1 (Video MP4 Format)
A Look In Tge Crystal Ball Environment & Education – Achieving sustainable development goals in nephrology care, research and education 2 (Video MP4 Format)
A Look In Tge Crystal Ball Environment & Education – Nephrology education Looking to the Future (Video MP4 Format)
A Look In Tge Crystal Ball Environment & Education – WATER SAVING COMPARISON AT DIFFERENT DIALYSATE FLOWS IN EXPANDED HEMODIALYSIS (Video MP4 Format)
Acute Kidney Injury – AKI in COVID-19 patients What is new (Video MP4 Format)
Acute Kidney Injury – AKI in non-COVID disasters (Video MP4 Format)
Acute Kidney Injury – AKI in the obstetric clinics One complication, jeopardizing two lives (Video MP4 Format)
Acute Kidney Injury – Intrinsic renal AKI, but not acute tubular necrosis So what (Video MP4 Format)
Acute Kidney Injury – Management of severe AKI in the ICU the place of RRTs (Video MP4 Format)
AKI The Good, The Bad & The Ugly – AKI biomarkers as prognostic marker for development of CKD (Video MP4 Format)
AKI The Good, The Bad & The Ugly – COMPARISON OF THE CHARACTERISTICS AND MORTALITY OF ACUTE KIDNEY INJURY IN PATIENTS (Video MP4 Format)
AKI The Good, The Bad & The Ugly – INCIDENCE OF NOSOCOMIAL ACUTE KIDNEY INJURY (AKI) IN A COHORT OF COMMUNITY-DWELLING (Video MP4 Format)
AKI The Good, The Bad & The Ugly – IS AKI IN COVID-19 PATIENTS ASSOCIATED WITH INCREASED LENGTH OF STAY AND MORTALITY (Video MP4 Format)
AKI The Good, The Bad & The Ugly – URINARY LEVELS OF SARS-COV-2 NUCLEOCAPSID PROTEIN PREDICTS AKI AND FATAL OUTCOME IN COVID-19 (Video MP4 Format)
Anaemia What Else – ENHANCED DEGRADATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE (Video MP4 Format)
Anaemia What Else – POOLED EFFICACY AND CARDIOVASCULAR SAFETY RESULTS OF 3 PLACEBO-CONTROLLED (Video MP4 Format)
Anaemia What Else – POST-MORTEM HEPATIC AND BONE MARROW IRON CONTENT IN HEMODIALYSIS PATIENTS A PROSPECTIVE COHORT STUDY (Video MP4 Format)
Anaemia What Else – REGIONAL EFFICACY AND SAFETY RESULTS OF ROXADUSTAT COMPARED WITH PLACEBO (Video MP4 Format)
Anaemia What Else – THE SHORT-TERM IMPACT OF HIGH DOSE INTRAVENOUS IRON USE ON RENAL FUNCTION (Video MP4 Format)
Basic Science in AKI – Inflammatory cascade in acute kidney injury (Video MP4 Format)
Basic Science in AKI – IRF8 IN CDC1 IS PROTECTIVE IN POST-ISCHEMIC ACUTE KIDNEY INJURY (Video MP4 Format)
Basic Science in AKI – SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) DETERMINES (Video MP4 Format)
Basic Science in AKI – THE LONG-TERM EFFECTS OF ACUTE KIDNEY INJURY ON INTESTINAL OXALATE-DEGRADING BACTERIA IN RATS (Video MP4 Format)
Basic Science in AKI – TUBULAR EPITHELIAL CELL POLYPLOIDY IS ESSENTIAL TO SURVIVE AKI BUT IT CONTRIBUTES (Video MP4 Format)
Basics & Clinics In Glomerulonephritis – CONTACTIN-1 IS A NOVEL ANTIGEN IN IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS (Video MP4 Format)
Basics & Clinics In Glomerulonephritis – LARGE SCALE VALIDATION OF THE NEW INTERNATIONAL PROGNOSTIC SCORE OF IGA NEPHROPATHY (Video MP4 Format)
Basics & Clinics In Glomerulonephritis – Mesenchymal Stem Cell Therapy for Glomerulonephritis (Video MP4 Format)
Basics & Clinics In Glomerulonephritis – MicroRNA and kidney pathophysiology (Video MP4 Format)
Basics & Clinics In Glomerulonephritis – PODOCYTE AND GLOMERULAR ENDOTHELIAL CELL DERIVED MICRORNAS (Video MP4 Format)
Beat Autoimmunity – IPTACOPAN (LNP023) A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR SAFELY (Video MP4 Format)
Beat Autoimmunity – LONG-TERM FOLLOW-UP OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS INCLUDED IN EUROPEAN (Video MP4 Format)
Beat Autoimmunity – SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS (Video MP4 Format)
Beat Autoimmunity – THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION (Video MP4 Format)
Beat Autoimmunity – VOCLOSPORIN INCREASES RENAL RESPONSE AT COMMONLY USED UPCR THRESHOLDS IN PATIENTS WITH LUPUS NEPHRITIS (Video MP4 Format)
Big Data & Nephrology – CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION A DANGEROUS COMBINATION (Video MP4 Format)
Big Data & Nephrology – QUALITY OF LIFE OVER TIME IN OLDER MEN AND WOMEN WITH ADVANCED CKD RESULTS FROM THE EQUAL STUDY (Video MP4 Format)
Big Data & Nephrology – The analysis of large public databases for study of human disease the UK Biobank example (Video MP4 Format)
Big Data & Nephrology – USE OF POTENTIALLY NEPHROTOXIC MEDICATIONS IN PERSONS WITH CHRONIC KID NEY DISEASE (Video MP4 Format)
Big Data & Nephrology – WHEN TO INITIATE DIALYSIS TO REDUCE MORTALITY AND CARDIOVASCULAR EVENTS IN ADVANCED CKD (Video MP4 Format)
Bones & Outcomes In CKD – DIAGNOSTIC ACCURACY OF BONE TURNOVER MARKERS IN RENAL OSTEODYSTROPHY (Video MP4 Format)
Bones & Outcomes In CKD – HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY (Video MP4 Format)
Bones & Outcomes In CKD – LONG-TERM SAFETY OF TENAPANOR FOR THE CONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CKD ON DIALYSIS (Video MP4 Format)
Bones & Outcomes In CKD – REAL-WORLD EFFECTIVENESS OF ETELCALCETIDE VS. CINACALCET IN US HEMODIALYSIS PATIENTS (Video MP4 Format)
Bones & Outcomes In CKD – VARIABILITY IN SERUM PHOSPHATE ASSESSED BY DIRECTIONAL CHANGE IS ASSOCIA- TED WITH INCREASED MORTALITY (Video MP4 Format)
Cells & Immunity – CKD DERIVED MUSCLE CELLS RETAIN PHENOTYPIC CHARACTERISTICS OF UREIC SARCOPENIA (Video MP4 Format)
Cells & Immunity – DEPOSITION OF PLATELET-DERIVED MICRO-PARTICLES IN PODOCYTES CONTRIBUTES TO DIABETIC NEPHROPATHY (Video MP4 Format)
Cells & Immunity – PHOSPHATE FACILITATES PHOSPHATURIA BY PIT-2-MEDIATED ACTIVATION OF ERK1 2 SIGNALLING (Video MP4 Format)
Cells & Immunity – PP2A PHOSPHATASE INHIBITION IS ANTI-FIBROTIC THROUGH SER77 PHOSPHORYLATION-MEDIATED (Video MP4 Format)
Cells & Immunity – Salt and immunity (Video MP4 Format)
CKD And Bone Mineral Disorders In CKD – Bone biopsy in clinical decision-making (Video MP4 Format)
CKD And Bone Mineral Disorders In CKD – Bone imaging and risk assessment in CKD (Video MP4 Format)
CKD And Bone Mineral Disorders In CKD – Bone turnover markers clinical utility in CKD (Video MP4 Format)
CKD And Bone Mineral Disorders In CKD – PTH, a troublesome hormone (Video MP4 Format)
Closing Session Nephrology Pearls – Basic Science and Translational Nephrology (Video MP4 Format)
Closing Session Nephrology Pearls – Epidemiology and Clinical Nephrology (Video MP4 Format)
Closing Session Nephrology Pearls – ESKD and Dialysis (Video MP4 Format)
Closing Session Nephrology Pearls – Kidney Transplantation (Video MP4 Format)
Cysts And Cancer – 4-WEEK ANTIBIOTIC THERAPY PREVENTS RECURRENT RENAL CYST INFECTIONS (Video MP4 Format)
Cysts And Cancer – Bardet-Biedle Syndrome from clinic to omics (Video MP4 Format)
Cysts And Cancer – CIRCULATING BIOMARKERS OF COLLAGEN TURNOVER ARE ASSOCIATED WITH DISEASE SEVERITY (Video MP4 Format)
Cysts And Cancer – INTERDEPENDENT REGULATION OF POLYCYSTIN EXPRESSION INFLUENCES STARVATION-INDUCED (Video MP4 Format)
Cysts And Cancer – Leveraging animal models for onconephrology research (Video MP4 Format)
Dialysis Heart & Vessels – BASELINE AND CORONARY ARTERY CALCIFICATION PROGRESSION MODULATES THE RISK OF DEATH (Video MP4 Format)
Dialysis Heart & Vessels – GLUCOSE DERIVATIVE INDUCED VASCULOPATHY IN CHILDREN ON PERITONEAL DIALYSIS (Video MP4 Format)
Dialysis Heart & Vessels – HIGHER MAGNESIUM DIALYSATE CONCENTRATION SIGNIFICANTLY IMPROVE SURVIVAL (Video MP4 Format)
Dialysis Heart & Vessels – PTH INDCUED ENDMT VIA MIR-29A-5P GSAP NOTCH1 PATHWAY CONTRIBUTED TO VALVULAR CALCIFICATION IN RATS WITH CKD (Video MP4 Format)
Dialysis Heart & Vessels – SNF472 ATTENUATES THE PROGRESSION OF FEMORAL ARTERY CALCIFICATION (Video MP4 Format)
Dialysis Nutrition & Outcomes – DIALYSIS WITHDRAWAL IN THE NETHERLANDS BETWEEN 2000-2020 TIME TRENDS AND CENTRE VARIATION (Video MP4 Format)
Dialysis Nutrition & Outcomes – HIGHER VARIABILITY OF SERUM PHOSPHATE IS ASSOCIATED WITH INCREASED MORTALITY (Video MP4 Format)
Dialysis Nutrition & Outcomes – Nutritional impact of HDF, a randomized trial (Video MP4 Format)
Dialysis Nutrition & Outcomes – TIME TRENDS IN PROBABILITY OF STARTING HOME DIALYSIS OVER A 20 YEAR PERIOD (Video MP4 Format)
Dialysis Nutrition & Outcomes – WEIGHT CHANGE AS A PREDICTOR OF MORTALITY IN CHRONIC HEMODIALYSIS PATIENTS (Video MP4 Format)
Dialysis Patterns Whats New – EFFICACY OF EXPANDED HEMODIALYSIS AT DIFFERENT DIALYSATE FLOWS (Video MP4 Format)
Dialysis Patterns Whats New – INCREASED VASCULAR REFILLING BY FEEDBACK-CONTROLLED ULTRAFILTRATION PROFILE (Video MP4 Format)
Dialysis Patterns Whats New – INTERMITTENT HEMODIALYSIS WITHOUT ANTICOAGULATION (Video MP4 Format)
Dialysis Patterns Whats New – THE EFFECT OF INCREMENTAL START OF HAEMODIALYSIS ON BLOOD PRESSURE (Video MP4 Format)
Dialysis Quality Of Life – Comprehensive Conservative Care what doctors say, what patients hear (Video MP4 Format)
Dialysis Quality Of Life – HEALTH-RELATED QUALITY OF LIFE (HRQOL) AND SYMPTOM BURDEN (Video MP4 Format)
Dialysis Quality Of Life – LUNG ULTRASOUND-GUIDED ULTRAFILTRATION IN HAEMODIALYSIS PATIENTS REDUCES (Video MP4 Format)
Dialysis Quality Of Life – THE SOCIETAL IMPACT OF DELAYED DIALYSIS INITIATION ASSOCIATED WITH DAPAGLIFLOZIN (Video MP4 Format)
Dialysis Quality Of Life – UTILITY OF A SINGLE ITCH-RELATED QUESTION AND THE SKINDEX-10 QUESTIONNAIRE FOR ASSESSING (Video MP4 Format)
Electrolytes And Urolithiasis – Calcium and magnesium disorders (Video MP4 Format)
Electrolytes And Urolithiasis – Disorders of phosphate balance (Video MP4 Format)
Electrolytes And Urolithiasis – Hypo- and hyperparathyroidism (Video MP4 Format)
Electrolytes And Urolithiasis – Potassium (Video MP4 Format)
Electrolytes And Urolithiasis – Vasopressin and renal water handling (Video MP4 Format)
Fluid, GFR & CO. – ESTIMATING ALBUMIN TO CREATININE RATIO FROM PROTEIN TO CREATININE RATIO (Video MP4 Format)
Fluid, GFR & CO. – FUNCTIONAL SODIUM MAGNETIC RESONANCE IMAGING OF HUMAN KIDNEY (Video MP4 Format)
Fluid, GFR & CO. – Hydration and CKD Neither too much nor too little (Video MP4 Format)
Fluid, GFR & CO. – PERCENTILES OF NORMAL MEASURED GLOMERULAR FILTRATION RATE BASED ON DATA FROM LIVING KIDNEY DONORS (Video MP4 Format)
Fluid, GFR & CO. – RATIO OF MEASURED GFR TO ESTIMATED GFR MAY PREDICT EARLY DEATH AND REQUIREMENT FOR DIALYSIS (Video MP4 Format)
Fluid, GFR & CO. – SALIVARY POTASSIUM FOLLOWS PLASMA POTASSIUM DYNAMICS IN HEMODIALYSIS PATIENTS (Video MP4 Format)
Genes & Kidney – DEMONSTRATED COMPARABLE OXALATE REDUCTION AND SAFETY IN CHILDREN (Video MP4 Format)
Genes & Kidney – Epigenetic DNA and histone modifications for CKD treatment (Video MP4 Format)
Genes & Kidney – INFLUENCE OF GENETIC VARIATION IN SLC7A13 AGT1 IN HUMAN CYSTINURIA (Video MP4 Format)
Genes & Kidney – KIDNEYNETWORK USING KIDNEY DERIVED GENE EXPRESSION DATA TO PREDICT (Video MP4 Format)
Genes & Kidney – PRIMARY KIDNEY DISEASE IMPACTS OUTCOME IN CKD PREGNANCIES (Video MP4 Format)
Haemo- And Peritoneal Dialysis – Choice of dialysis mode and adapting prescriptions of PD and HD for patients with cirrosis and ascites (Video MP4 Format)
Haemo- And Peritoneal Dialysis – How can physicians improve AV fistula patency (Video MP4 Format)
Haemo- And Peritoneal Dialysis – Incremental dialysis in PD and HD (Video MP4 Format)
Haemo- And Peritoneal Dialysis – Rapid bedside testing for the diagnosis of PD peritonitis (Video MP4 Format)
Haemo- And Peritoneal Dialysis – Role of bioimpedance in aiding clinical decision on target weight (both for PD and HD) (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Indications, technical aspects and procedures of renal biopsy (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Introduction to Molecular Renal Pathology (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Practical aspects and procedures of renal biopsy (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Review and discussion of 20 selected cases with virtual microscopy, immunofluorescence 1 (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Review and discussion of 20 selected cases with virtual microscopy, immunofluorescence 2 (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Review and discussion of 20 selected cases with virtual microscopy, immunofluorescence 3 (Video MP4 Format)
Hands-on Course On Renal Molecular Pathology – Review and discussion of 20 selected cases with virtual microscopy, immunofluorescence 4 (Video MP4 Format)
Hypertension & Omics – Fibromuscular dysplasia much more than a rare disease (Video MP4 Format)
Hypertension & Omics – HIGH DIETARY PHOSPHATE INTAKE UND INTRA-CARDIAC SYNTHESIS OF FIBROBLAST (Video MP4 Format)
Hypertension & Omics – PROTEOMIC PROFILING OF GLOMERULI FROM KIDNEYS WITH HYPERTENSIVE NEPHROPATHY (Video MP4 Format)
Hypertension & Omics – SINGLE CELL SEQUENCING REVEALS TRANSCRIPTIONAL SIGNATURES AND CELL (Video MP4 Format)
Hypertension & Omics – Sodium from gut microbiome to inflammation and hypertension (Video MP4 Format)
Hypertension, Diabetes, Cardiovascular Diseases In CKD – A death knell for supplemented Vitamin K to Improve Vascular Stiffness in CKD (Video MP4 Format)
Hypertension, Diabetes, Cardiovascular Diseases In CKD – Hyperkalemia in the new era of triple ACEARB and Finerenone no more a cause of concern (Video MP4 Format)
Hypertension, Diabetes, Cardiovascular Diseases In CKD – Is CV risk in CKD patients amplified by COVID-19 (Video MP4 Format)
Hypertension, Diabetes, Cardiovascular Diseases In CKD – The role of non-invasive tools for assessing the cardiovascular risk of obese diabetic patients (Video MP4 Format)
Hypertension, Diabetes, Cardiovascular Diseases In CKD – Therapies for slowing the progression of diabetic kidney disease from renin angiotensin system (Video MP4 Format)
Interventions In CKD – AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS (Video MP4 Format)
Interventions In CKD – EFFICACY OF INTRAVENOUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY (Video MP4 Format)
Interventions In CKD – Potassium and mortality (Video MP4 Format)
Interventions In CKD – SAFETY AND EFFICACY OF PATIROMER FOR HYPERKALAEMIA IN PATIENTS (Video MP4 Format)
Interventions In CKD – SAFETY OF BARDOXOLONE METHYL IN PEDIATRIC PATIENTS WITH ALPORT SYNDROME IN CARDINAL PHASE 3 TRIAL (Video MP4 Format)
KDIGO BP In CKD Controversial Guideline 2021 – BP measurement in the office Standardized measurement is vital and feasible Con (Video MP4 Format)
KDIGO BP In CKD Controversial Guideline 2021 – BP measurement in the office Standardized measurement is vital and feasible Pro (Video MP4 Format)
KDIGO BP In CKD Controversial Guideline 2021 – Lowering systolic BP in CKD to 120 mm Hg is reasonable Con (Video MP4 Format)
KDIGO BP In CKD Controversial Guideline 2021 – Lowering systolic BP in CKD to 120 mm Hg is reasonable Pro (Video MP4 Format)
Kidney Transplantation – How close are we to skip kidney biopsy and to diagnose kidney rejection with biomarkers (Video MP4 Format)
Kidney Transplantation – Recurrent glomerulonephritis following renal transplantation (Video MP4 Format)
Kidney Transplantation – Rejection episodes during COVID-19 pandemic Who to treat How to treat (Video MP4 Format)
Kidney Transplantation – Should we treat osteoporosis, hyperparathyroidism and hypercalcemia after kidney transplantation (Video MP4 Format)
Kids & Kidney – Diagnosis and management of nephrotic syndrome in children clinical practice guidelines from IPNA, ESPN and ERKNet (Video MP4 Format)
Kids & Kidney – HEMODIAFILTRATION IS ASSOCIATED WITH REDUCED INFLAMMATION AND INCREASED BONE (Video MP4 Format)
Kids & Kidney – OFATUMUMAB OR RITUXIMAB FOR CHILDREN WITH STEROID-DEPENDENT NEPHROTIC SYNDROME (Video MP4 Format)
Kids & Kidney – RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3B TRIAL OF TOLVAPTAN IN THE TREATMENT (Video MP4 Format)
Kids & Kidney – SHORT COURSE DAILY LOW-DOSE PREDNISOLONE AT THE TIME OF UPPER RESPIRATORY (Video MP4 Format)
Moderated Mini-Orals 4 – CALPROTECTIN IS A NOVEL CONTRIBUTING FACTOR IN VASCULAR CALCIFICATION AND A PREDICTOR (Video MP4 Format)
Moderated Mini-Orals 4 – CD47 BLOCKADE AMELIORATES AUTOIMMUNE VASCULITIS VIA THE EFFEROCYTOSIS OF NEUTROPHIL (Video MP4 Format)
Moderated Mini-Orals 4 – CLEARED PODOCYTES AND NORMAL KIDNEY FUNCTION IN CLASSICAL FABRY MALES 15 YEARS (Video MP4 Format)
Moderated Mini-Orals 4 – EFFECTS OF SHORT-TERM POTASSIUM CHLORIDE SUPPLEMENTATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (Video MP4 Format)
Moderated Mini-Orals 4 – ESTIMATING THE BUDGET IMPACT OF DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE (Video MP4 Format)
Moderated Mini-Orals 4 – HIGHLY SENSITIVE FLOW CYTOMETRIC DETECTION OF RESIDUAL B-CELLS AFTER RITUXIMAB (Video MP4 Format)
Moderated Mini-Orals 4 – KLOTHO AS A BIOMARKER OF SUBCLINICAL CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE (Video MP4 Format)
Moderated Mini-Orals 4 – NATURAL IMMUNISATION AGAINST ATHEROSCLEROSIS IN BEARS DURING HIBERNATION (Video MP4 Format)
Moderated Mini-Orals 4 – NON-AMYLOID TYPE OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE CLINICAL (Video MP4 Format)
Moderated Mini-Orals 4 – OUTCOME OF DIFFERENT INDUCTION REGIMENS IN ANCA-ASSOCIATED GLOMERULONEPHRITIS (Video MP4 Format)
Moderated Mini-Orals 4 – PREGNANCY OUTCOMES AND COMPLICATIONS IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS (Video MP4 Format)
Moderated Mini-Orals 4 – URINARY DICKKOPF-3 (UDKK3) A NEW BIOMARKER FOR LONG-TERM CKD PROGRESSION AND MORTALITY (Video MP4 Format)
Moderated Mini-Orals 4 – URINE METABOLITE LEVELS OF CKD PATIENTS ARE ASSOCIATED WITH ADVERSE KIDNEY OUTCOMES AND MORTALITY (Video MP4 Format)
Nephropathology – EMA ESOT consensus redefinition of rejection endpoints in kidney transplantation (Video MP4 Format)
Nephropathology – ERKNet consensus on obstructive uropathy renal dysplasia (Video MP4 Format)
Nephropathology – FSGS and minimal change glomerulopathy what can nephropathology contribute (Video MP4 Format)
Nephropathology – Nephropathology of Covid-19 (Video MP4 Format)
Nephropathology – The spectrum of infection-associated glomerulonephritis (Video MP4 Format)
Outcomes in PD – Assisted PD strategies and outcomes (Video MP4 Format)
Outcomes in PD – CARDIAC GEOMETRY, FUNCTION, AND REMODELING PATTENRS AND LUNG WATER (Video MP4 Format)
Outcomes in PD – LITHIUM PRESERVES PERITONEAL MEMBRANE INTEGRITY BY REDUCING MESOTHELIAL CELL àB-CRYSTALLIN (Video MP4 Format)
Outcomes in PD – PD INDUCED ARTERIOLAR AND PERITONEAL PATHOMECHANISMS ARE PARTIALLY (Video MP4 Format)
Outcomes in PD – TOWARDS RAPID BEDSIDE TESTING FOR THE DIAGNOSIS OF PD-ASSOCIATED COMPLICATIONS (Video MP4 Format)
Pathology Meets Clinics – DEEP-LEARNING ENABLED QUANTIFICATION OF SINGLE-CELL SINGLE-MRNA TRANSCRIPTS (Video MP4 Format)
Pathology Meets Clinics – EXPERIMENTAL NEPHROTIC SYNDROME (Video MP4 Format)
Pathology Meets Clinics – SPARSENTAN IMPROVES GLOMERULAR BLOOD FLOW AND AUGMENTS PROTECTIVE TISSUE REMODELING (Video MP4 Format)
Pathology Meets Clinics – Update on diagnosis and therapy for non-AL amyloidosis (Video MP4 Format)
Pathophysiological Pathways In CKD – A RENAL-CARDIO INFLAMMATORY AXIS MEDIATES CARDIAC DYSFUNCTION IN CKD VIA IL-33-ST2 (Video MP4 Format)
Pathophysiological Pathways In CKD – DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE (Video MP4 Format)
Pathophysiological Pathways In CKD – DICKKOPF-3 (DKK3) LINKS RECIPROCAL LUNG AND KIDNEY INJURY IN MICE AND HUMANS (Video MP4 Format)
Pathophysiological Pathways In CKD – OBESITY AS A CAUSE OF KIDNEY DISEASE INSIGHTS FROM MENDELIAN RANDOMISATION STUDIES (Video MP4 Format)
Pathophysiological Pathways In CKD – PREDICTING OUTCOMES IN ANCA ASSOCIATED VASCULITIS THE COMPLETE SCOTTISH EXPERIENCE (Video MP4 Format)
Plants, Coffee & More – Coffee and mortality in CKD (Video MP4 Format)
Plants, Coffee & More – DIET QUALITY, PROTEIN-BOUND URAEMIC TOXINS AND GASTROINTESTINAL MICROBIOME IN CHRONIC KIDNEY DISEASE (Video MP4 Format)
Plants, Coffee & More – Plant based diets in CKD benefits and risks (Video MP4 Format)
Plants, Coffee & More – PROBIOTIC L.CASEI ZHANG SLOWS THE PROGRESSION OF ACUTE AND CHRONIC KID- NEY DISEASE (Video MP4 Format)
Plants, Coffee & More – ULTRA-PROCESSED FOOD CONSUMPTION AND RISK OF INCIDENT CHRONIC KIDNEY DISEASE (Video MP4 Format)
Plenary Lecture 1 – Development of novel, mechanism-based therapies for kidney diseases (Video MP4 Format)
Plenary Lecture 2 – A novel biological mechanism underlying renal cystogenesis and tumorigenesis (Video MP4 Format)
Plenary Lecture 3 – Integrating multiomics data for a better understanding of kidney disease (Video MP4 Format)
Prevention Of AKI – A RANDOMISED DOSE RANGING, PLACEBO-CONTROLLED, PHASE II STUDY ASSESSING THE EFFICACY (Video MP4 Format)
Prevention Of AKI – ACID-BASE BALANCE DURING IN-SERIES EXTRACORPOREAL CARBON DIOXIDE REMOVAL (Video MP4 Format)
Prevention Of AKI – AKI and cancer (Video MP4 Format)
Prevention Of AKI – PREDICTIVE VALUE OF PLASMA NGALHEPCIDIN-25 FOR MAJOR ADVERSE KIDNEY EVENTS AFTER CARDIAC SURGERY (Video MP4 Format)
Prevention Of AKI – THE PREDICTIVE ABILITY OF URINARY BIOMARKERS FOR PROGRESSION OF ACUTE KIDNEY INJURY IN CRITICAL ILLNESS (Video MP4 Format)
Primary & Secondary GN, Vasculitis And Autoimmune Diseases – Anti-GBM disease (Video MP4 Format)
Primary & Secondary GN, Vasculitis And Autoimmune Diseases – Immune-mediated interstitial nephritis (Video MP4 Format)
Primary & Secondary GN, Vasculitis And Autoimmune Diseases – Immune-mediated kidney disease and COVID-19 (Video MP4 Format)
Primary & Secondary GN, Vasculitis And Autoimmune Diseases – Neutrophil extracellular traps in immune-mediated glomerular diseases (Video MP4 Format)
Primary & Secondary GN, Vasculitis And Autoimmune Diseases – Risk assessment for progression of IgA nephropathy (Video MP4 Format)
Protect The Membrane – ASSOCIATION OF SINGLE AND SERIAL MEASURES OF SERUM PHOSPHORUS WITH ADVERSE OUTCOMES (Video MP4 Format)
Protect The Membrane – DECLINING PERITONEAL HOST DEFENCES REVEALED BY EX-VIVO CYTOKINE RELEASE ASSAY (Video MP4 Format)
Protect The Membrane – MESENCHYMAL STEM CELL EXOSOMES AMELIORATE MICE PERITONEAL FIBROSIS INDUCED (Video MP4 Format)
Protect The Membrane – Mistakes we make in treating peritonitis (Video MP4 Format)
Protect The Membrane – PROTEOMIC PROFILE OF MESOTHELIAL EXOSOMES ISOLATED FROM PERITONEAL DIALYSIS (Video MP4 Format)
Stones and Brains – ACIDOSIS AND ALKALI THERAPY ARE ASSOCIATED WITH TRANSCRIPTIONAL CHANGES (Video MP4 Format)
Stones and Brains – Chronic Kidney Disease and Neurological Disorders Uremic Toxins as a piece of the incomplete puzzle (Video MP4 Format)
Stones and Brains – HYPERURICEMIA HAS VASOACTIVE EFFECTS IN CHOLESTEROL CRYSTAL-INDUCED ACUTE KIDNEY INJURY (Video MP4 Format)
Stones and Brains – Papal renal stone disease from Saint Peter to St. John Paul II (Video MP4 Format)
Stones and Brains – SERUM URIC ACID AND KIDNEY DISEASE MEASURES INDIPENDENTLY PREDICT CARDIOVASCULAR (Video MP4 Format)
Stop Diabetes – DUAL BLOCKADE OF ENDOTHELIN A RECEPTOR (ETA) AND SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) (Video MP4 Format)
Stop Diabetes – GLOMERULI PROTEOME ANALYSIS REVEALS EARLY DIFFERENCES BETWEEN PRE-EXISTING (Video MP4 Format)
Stop Diabetes – LIPOTOXICITY MEDIATED BY GPR43 ACTIVATION CONTRIBUTES TO PODOCYTE INJURY IN DIABETIC NEPHROPATHY (Video MP4 Format)
Stop Diabetes – MIR-155 SOCS1 REGULATORY LOOP INFLUENCES DIABETIC KIDNEY DISEASE BY JAK STAT PATHWAY MODULATION (Video MP4 Format)
Stop Diabetes – SERUM INTERLEUKIN-6 LEVELS PREDICT RENAL DISEASE PROGRESSION IN DIABETIC KIDNEY DISEASE (Video MP4 Format)
Surviving CKD – CKD and prognosis, mortality, hospitalization (Video MP4 Format)
Surviving CKD – EARLY LIFE FACTORS AND ADULT KIDNEY FUNCTION ESTIMATED BY CYSTATIN C (Video MP4 Format)
Surviving CKD – METABOLIC PROFILING AS A MARKER OF CARDIOVASCULAR DISEASE AND ARTERIAL (Video MP4 Format)
Surviving CKD – OSTEOPONTIN AND ITS ASSOCIATION WITH ADVERSE EVENTS IN THE GERMAN CHRONIC KIDNEY DISEASE STUDY (Video MP4 Format)
Surviving CKD – THE IMPORTANCE OF ADDRESSING MULTIPLE RISK MARKERS IN TYPE 2 DIABETES (Video MP4 Format)
Symposium 0.1 Late Breaking Clinical Trials – A lung ultrasound guided treatment strategy (LUST) in end stage kidney disease patients at high cardiovascular risk (Video MP4 Format)
Symposium 0.1 Late Breaking Clinical Trials – Effects of Dapagliflozin on major adverse kidney events in patients with focal segmental glomerulosclerosis (Video MP4 Format)
Symposium 0.1 Late Breaking Clinical Trials – Interim analysis of a phase 2 dose ranging study to investigate the efficacy and safety of Iptacopan (Video MP4 Format)
Symposium 0.1 Late Breaking Clinical Trials – Orally administered C5AR inhibitor Avacopan in a randomized, double blind placebocontrolled study (Video MP4 Format)
Symposium 0.2 ERA-EDTA Registry – International comparison of trends in kidney transplantation rates in Europe (Video MP4 Format)
Symposium 0.2 ERA-EDTA Registry – Uraemic symptoms and uraemic toxins in the EQUAL study (Video MP4 Format)
Symposium 0.2 ERA-EDTA Registry – Work status and work ability of patients treated with kidney replacement therapy (Video MP4 Format)
Symposium 0.3 Hot Topics In Nephrology – Changes in the landscape of contrast nephropathy (Video MP4 Format)
Symposium 0.3 Hot Topics In Nephrology – New KDIGO guidelines on the management of glomerulonephritis (Video MP4 Format)
Symposium 0.3 Hot Topics In Nephrology – The role, use and pathophysiology of the complement system (Video MP4 Format)
Symposium 0.4 2021 Pearls Of NDT And CKJ – CKJ Editor selects 2 Speakers from the Editorial Board 1 (Video MP4 Format)
Symposium 0.4 2021 Pearls Of NDT And CKJ – CKJ Editor selects 2 Speakers from the Editorial Board 2 (Video MP4 Format)
Symposium 0.4 2021 Pearls Of NDT And CKJ – NDT Editor selects 2 Speakers from associate Editors 1 (Video MP4 Format)
Symposium 0.4 2021 Pearls Of NDT And CKJ – NDT Editor selects 2 Speakers from associate Editors 2 (Video MP4 Format)
Symposium 0.5 Avoiding A Crash Landing Of Nephrology By Creating Awareness – The burden of COVID-19 on the population with kidney disease (Video MP4 Format)
Symposium 0.5 Avoiding A Crash Landing Of Nephrology By Creating Awareness – The burden of kidney disease the unbearable lightness of neglect (Video MP4 Format)
Symposium 0.5 Avoiding A Crash Landing Of Nephrology By Creating Awareness – US Actions to Create Awareness on Kidney Disease and International Cooperation to Address Kidney Failure (Video MP4 Format)
Symposium 0.6 Future Scenarios For Renal Disease – Climate changes and nephrology (Video MP4 Format)
Symposium 0.6 Future Scenarios For Renal Disease – Demographic changes in different part of the world (Video MP4 Format)
Symposium 0.6 Future Scenarios For Renal Disease – Planetary health and burden of life style diseases what saves the planet saves our health (Video MP4 Format)
Symposium 0.7 Climate Change And Health The Opinion Of The Younger Generation – Global perspective on the climate crisis as a crisis of health (Video MP4 Format)
Symposium 0.7 Climate Change And Health The Opinion Of The Younger Generation – Perspectives for the coming medical generation regarding the climate crisis (Video MP4 Format)
Symposium 0.7 Climate Change And Health The Opinion Of The Younger Generation – Repercussions of heatwaves for kidney patients (Video MP4 Format)
Symposium 1.1 Acid-base Balance In Health And Kidney Disease – Acidosis in patients with kidney transplant origin and impact on outcome (Video MP4 Format)
Symposium 1.1 Acid-base Balance In Health And Kidney Disease – Alkali treatment and amelioration of kidney disease uncovering underlying mechanisms (Video MP4 Format)
Symposium 1.1 Acid-base Balance In Health And Kidney Disease – The renal response to acid(osis) (Video MP4 Format)
Symposium 1.2 A New Look At Tubular Functions – How to build a tubular epithelium (Video MP4 Format)
Symposium 1.2 A New Look At Tubular Functions – Inherited defects of the proximal tubule reveal important pathways (Video MP4 Format)
Symposium 1.2 A New Look At Tubular Functions – Paracellular transport via claudins is essential for normal kidney function (Video MP4 Format)
Symposium 1.3 Phosphate And Other Minerals – Inhibition of intestinal and renal phosphate transport as new strategy to treat hyperphosphatemia in CKD (Video MP4 Format)
Symposium 1.3 Phosphate And Other Minerals – Phosphate and vascular calcification new avenues for treatment (Video MP4 Format)
Symposium 1.4 Electrolytes Renal Transport And Endocrine Control – Gender effects on tubular (salt) handling (Video MP4 Format)
Symposium 1.4 Electrolytes Renal Transport And Endocrine Control – Glucocorticoids and hypertension revisited (Video MP4 Format)
Symposium 1.4 Electrolytes Renal Transport And Endocrine Control – Renal potassium sensing and control of blood pressure (Video MP4 Format)
Symposium 2.1 Diagnosis And Treatment Of Rare Disease In Children And Adult CKD – Is ADPKD a paediatric disease (Video MP4 Format)
Symposium 2.1 Diagnosis And Treatment Of Rare Disease In Children And Adult CKD – Mendelian randomization reveals causative factors for kidney function impairment (Video MP4 Format)
Symposium 2.1 Diagnosis And Treatment Of Rare Disease In Children And Adult CKD – Treatment of patients with X-linked hypophosphatemia with borusumab advances and limitations (Video MP4 Format)
Symposium 2.2 Extracellular Vesicles And Kidney Diseases From Bio-markers To Therapeutic Bio-products – EVs as markersmediators of vascular ageing (Video MP4 Format)
Symposium 2.2 Extracellular Vesicles And Kidney Diseases From Bio-markers To Therapeutic Bio-products – Exosomes and microvesicles as biomarkers in renal physiology and diseases (Video MP4 Format)
Symposium 2.2 Extracellular Vesicles And Kidney Diseases From Bio-markers To Therapeutic Bio-products – Extracellular vesicles from urine and beyond (Video MP4 Format)
Symposium 2.3 Preeclampsia and kidney in 2021 – Endothelial dysfunction and activation in preeclampsia (Video MP4 Format)
Symposium 2.3 Preeclampsia and kidney in 2021 – Preeclampsia and future renal disease (Video MP4 Format)
Symposium 2.3 Preeclampsia and kidney in 2021 – Senescence and preeclampsia (Video MP4 Format)
Symposium 2.4 Networks And Registries In Rare Kidney Disease – ERKNet and its future perspectives (Video MP4 Format)
Symposium 2.4 Networks And Registries In Rare Kidney Disease – PKD registries (Video MP4 Format)
Symposium 2.4 Networks And Registries In Rare Kidney Disease – Registries in paediatric nephrology (Video MP4 Format)
Symposium 2.5 Updates On ADPKD – Imaging and genotyping to predict the outcome of ADPKD (Video MP4 Format)
Symposium 2.5 Updates On ADPKD – Metabolic reprogramming in ADPKD (Video MP4 Format)
Symposium 2.5 Updates On ADPKD – The role of chloride secretion in ADPKD (Video MP4 Format)
Symposium 2.6 An Integrated View Of ADTKD An Emerging Clinical And Genetic Entity – ADTKD-MUC1 from diagnostics to mechanisms (Video MP4 Format)
Symposium 2.6 An Integrated View Of ADTKD An Emerging Clinical And Genetic Entity – Cellular mechanisms, genotype to phenotype (Video MP4 Format)
Symposium 2.6 An Integrated View Of ADTKD An Emerging Clinical And Genetic Entity – Clinical and genetic spectra of ADTKD (Video MP4 Format)
Symposium 3.1 Covid-19 Pandemic – COVID-19 and history – a perspective from the great influenza pandemic of 1918 (Video MP4 Format)
Symposium 3.1 Covid-19 Pandemic – COVID-19 in Europe – clinical experience and learnings (Video MP4 Format)
Symposium 3.1 Covid-19 Pandemic – COVID-19 trials Lessons for the future (Video MP4 Format)
Symposium 3.2 News In Glomerulonephritis Treatment – GWAS in glomerular diseases (Video MP4 Format)
Symposium 3.2 News In Glomerulonephritis Treatment – IgA nephropathy is immunosuppression needed (Video MP4 Format)
Symposium 3.2 News In Glomerulonephritis Treatment – Vasculitis and complement inhibition (Video MP4 Format)
Symposium 3.3 Membranous Nephropathy Insights From Recent Clinical Trials – Back to basics Cyclophosphamide steroids (Video MP4 Format)
Symposium 3.3 Membranous Nephropathy Insights From Recent Clinical Trials – Rituximab as first line therapy (Video MP4 Format)
Symposium 3.3 Membranous Nephropathy Insights From Recent Clinical Trials – The role of anti-PLA2R monitoring (Video MP4 Format)
Symposium 3.4 Onconephrology – Cancer immunotherapies (checkpoint inhibitors, CAR-T cells, IL-2) and the kidney (Video MP4 Format)
Symposium 3.4 Onconephrology – Haemathological disorders in transplant recipients (Video MP4 Format)
Symposium 3.4 Onconephrology – High cut-off filters and multiple myeloma (Video MP4 Format)
Symposium 3.5 Complicated lupus nephritis – Improved clarity of definitions and classification of glomerular lesions in lupus nephritis (Video MP4 Format)
Symposium 3.5 Complicated lupus nephritis – Management of refractory lupus nephritis (Video MP4 Format)
Symposium 3.5 Complicated lupus nephritis – Urinary exosomal miRNA expression profile in lupus nephritis (Video MP4 Format)
Symposium 3.6 ANCA vasculitis prognostic and treatment – ANCA vasculitis and treatment Where are we now (Video MP4 Format)
Symposium 3.6 ANCA vasculitis prognostic and treatment – Renal risk score for ANCA vasculitis (Video MP4 Format)
Symposium 3.6 ANCA vasculitis prognostic and treatment – Urinary CD163 in antineutrophil cytoplasm antibody-associated glomerulonephritis (Video MP4 Format)
Symposium 3.7 Kidney Stones – ABC of Randall’s plaques and stones from rare diseases to calcium nephrolithiasis (Video MP4 Format)
Symposium 3.7 Kidney Stones – From crystals to CKD (Video MP4 Format)
Symposium 3.7 Kidney Stones – Urate transporters, gout and urate nephropathy (Video MP4 Format)
Symposium 3.8 Up-to-date On Alport Syndrome – Linking basement membrane biology to glomerular disease (Video MP4 Format)
Symposium 3.8 Up-to-date On Alport Syndrome – New pathogenetic mechanisms and therapeutic implications (Video MP4 Format)
Symposium 3.8 Up-to-date On Alport Syndrome – Ongoing clinical trials (Video MP4 Format)
Symposium 3.9 The Nephrotoxicity Of Commonly Used Medications What Is The Evidence And What Are The Alternatives – Oral anticoagulants (Video MP4 Format)
Symposium 3.9 The Nephrotoxicity Of Commonly Used Medications What Is The Evidence And What Are The Alternatives – Paracetamol (Video MP4 Format)
Symposium 3.9 The Nephrotoxicity Of Commonly Used Medications What Is The Evidence And What Are The Alternatives – Proton pump inhibitors (Video MP4 Format)
Symposium 4.1 New treatment targets to halt CKD progression – Non-steroidal MRA – an emerging option (Video MP4 Format)
Symposium 4.1 New treatment targets to halt CKD progression – SGLT2-inhibition – the new standard (Video MP4 Format)
Symposium 4.1 New treatment targets to halt CKD progression – Targeting inflammation pathways – the future (Video MP4 Format)
Symposium 4.2 Microbiome in CKD – Exploring functional interactions between microbiota and host (Video MP4 Format)
Symposium 4.2 Microbiome in CKD – Microbiota in CKD how promising are gut-targeted approaches (Video MP4 Format)
Symposium 4.2 Microbiome in CKD – Personalized targeting of the microbiome (Video MP4 Format)
Symposium 4.3 Uraemic Toxicities – Uraemic toxins and endothelium (Video MP4 Format)
Symposium 4.3 Uraemic Toxicities – Uraemic toxins and macrophages (Video MP4 Format)
Symposium 4.3 Uraemic Toxicities – Uric acid and allopurinol in CKD a paradigm change (Video MP4 Format)
Symposium 4.4 CKD And Metabolic Disorders The Common Cognitive Outcome – Clinical testing for cognitive function in CKD patients (Video MP4 Format)
Symposium 4.4 CKD And Metabolic Disorders The Common Cognitive Outcome – Cognitive impairment and albuminuriahypertension (Video MP4 Format)
Symposium 4.4 CKD And Metabolic Disorders The Common Cognitive Outcome – Cognitive impairment in CKD (Video MP4 Format)
Symposium 4.5 Preventing Kidney Ageing – Non-genetic factors driving kidney ageing (Video MP4 Format)
Symposium 4.5 Preventing Kidney Ageing – Preserving Klotho expression (Video MP4 Format)
Symposium 4.5 Preventing Kidney Ageing – The potential influence of the genetic background (Video MP4 Format)
Symposium 4.6 New Nutritional Targets In CKD – Are low or very low protein diets still useful and attractive treatment in CKD (Video MP4 Format)
Symposium 4.6 New Nutritional Targets In CKD – Ketogenic diet a new tool to improve renal cyst growth in ADPKD (Video MP4 Format)
Symposium 4.6 New Nutritional Targets In CKD – Role of kidney proximal tubules to balance nutrient and uremic toxins levels (Video MP4 Format)
Symposium 4.7 SGLT2-Inhibitors In CKD Without Diabetes – How do SGLT2 inhibitors work (Video MP4 Format)
Symposium 4.7 SGLT2-Inhibitors In CKD Without Diabetes – Non-diabetic heart failure and CKD (Video MP4 Format)
Symposium 4.7 SGLT2-Inhibitors In CKD Without Diabetes – What does imaging tell us (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – Clinical insight How should we use SGLT2 inhibitors in nephrology Discussion (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – Clinical insight How should we use SGLT2 inhibitors in nephrology (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – DAPA-CKD thinking beyond kidney disease (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – FIDELIO-DKD – CV outcomes including atrial fibrillation 1 (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – FIDELIO-DKD – CV outcomes including atrial fibrillation 2 (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – FIDELIO-DKD – CV outcomes including atrial fibrillation 3 (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – FIDELIO-DKD – Renal efficacy & safety (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – Summary (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – The Big Three how RASi, SGLT2i & MRA (Video MP4 Format)
Symposium 4.8 Randomized Trials – Slowing The Progression Of CKD – The DAPA-CKD trial (Video MP4 Format)
Symposium 5.1 Non-dialysing In The 21st Century – Dialysis comorbidities and outcome (Video MP4 Format)
Symposium 5.1 Non-dialysing In The 21st Century – End of life in ESKD Complex decision interaction among the patient, the family and the nephrologist (Video MP4 Format)
Symposium 5.2 COVID-19 in haemodialysis patients – Infection control in dialysis units (Video MP4 Format)
Symposium 5.2 COVID-19 in haemodialysis patients – Outcomes in dialysis patients infected with SARS-CoV-2 (Video MP4 Format)
Symposium 5.2 COVID-19 in haemodialysis patients – Prevention strategies for minimizing SARS-CoV-2 infection in dialysis facilities (Video MP4 Format)
Symposium 5.3 Innovations In Haemodialysis – How to reduce organ ischemia during haemodialysis can modern technologies help us (Video MP4 Format)
Symposium 5.3 Innovations In Haemodialysis – New haemodialysis therapies HDx therapy new membranes and others Do they mean any real improvement (Video MP4 Format)
Symposium 5.3 Innovations In Haemodialysis – The long journey towards a portable wearable dialysis What can we expect in the future (Video MP4 Format)
Symposium 5.4 Volume And Blood Pressure Control In Dialysis – Intradialytic hypertension an ignored killer (Video MP4 Format)
Symposium 5.4 Volume And Blood Pressure Control In Dialysis – The dialysis prescription for optimal volume control a KDIGO report (Video MP4 Format)
Symposium 5.4 Volume And Blood Pressure Control In Dialysis – The timing of Intradialytic hypotension (Video MP4 Format)
Symposium 5.5 Everyday Issues In Dialysis – How to choose the best sodium, potassium and bicarbonate level for an individual patient (Video MP4 Format)
Symposium 5.5 Everyday Issues In Dialysis – How to dose haemodialysis KtV, signs-symptoms, blood pressure, convection volume, so mething else (Video MP4 Format)
Symposium 5.5 Everyday Issues In Dialysis – How to incorporate patient related outcome measures into everyday dialysis care (Video MP4 Format)
Symposium 6.1 News In Peritoneal Dialysis – Biocompatible solutions and new osmotic agents (Video MP4 Format)
Symposium 6.1 News In Peritoneal Dialysis – Growth of peritoneal dialysis post-COVID-19 (Video MP4 Format)
Symposium 6.1 News In Peritoneal Dialysis – Incremental peritoneal dialysis prescription (Video MP4 Format)
Symposium 6.2 Volume Control In Peritoneal Dialysis – Does bioimpedance have a role in volume control (Video MP4 Format)
Symposium 6.2 Volume Control In Peritoneal Dialysis – The anuric patient is there a space for weekly hypertonic solutions (Video MP4 Format)
Symposium 6.2 Volume Control In Peritoneal Dialysis – Which biomarkers should we use (Video MP4 Format)
Symposium 6.3 PD vs HD Similarities And Differences An Endless Debate – Regulation of central haemodynamics and blood pressure (Video MP4 Format)
Symposium 6.3 PD vs HD Similarities And Differences An Endless Debate – Sleep apnea and sleep quality in dialysis patients an emerging cardiovascular risk factor (Video MP4 Format)
Symposium 6.3 PD vs HD Similarities And Differences An Endless Debate – Technical methods for volume evaluation in ESKD (Video MP4 Format)
Symposium 7.1 Translational Research In Kidney Transplant From Bench To Beside – Cell-free DNA a valuable tool to monitor acute rejection after kidney transplantation (Video MP4 Format)
Symposium 7.1 Translational Research In Kidney Transplant From Bench To Beside – Genetic diagnostic biomarkers and new predictors of outcomes in kidney transplantation (Video MP4 Format)
Symposium 7.1 Translational Research In Kidney Transplant From Bench To Beside – T-cell exhaustion in kidney transplant recipients (Video MP4 Format)
Symposium 7.2 Recent advances in kidney transplantation focus on immunity – Immunologic monitoring and biomarkers in kidney transplant recipients (Video MP4 Format)
Symposium 7.2 Recent advances in kidney transplantation focus on immunity – NON-HLA Incompatibilities what’s new (Video MP4 Format)
Symposium 7.2 Recent advances in kidney transplantation focus on immunity – Targeting immuno-inflammation in kidney transplantation a new weapon against organ fibrosis (Video MP4 Format)
Symposium 7.3 Transplant Clinical Medicine – Deceased Donor-initiated Chains a way to avoid long waiting list (Video MP4 Format)
Symposium 7.3 Transplant Clinical Medicine – Graft loss in non adherent patients ethical challenges (Video MP4 Format)
Symposium 7.3 Transplant Clinical Medicine – Organ preservation and reconditioning- the dream comes true (Video MP4 Format)
Symposium 7.4 New Mechanisms Of Graft Damage In Kidney Transplantation – Inflammaging and complement system from acute kidney injury to chronic graft damage (Video MP4 Format)
Symposium 7.4 New Mechanisms Of Graft Damage In Kidney Transplantation – Machine perfusion optimizing the protocol for better preservation (Video MP4 Format)
Symposium 7.4 New Mechanisms Of Graft Damage In Kidney Transplantation – Preserving the donor new therapeutic approaches (Video MP4 Format)
Symposium 8.1 New Concepts In Cardiovascular Disease In CKD Patients – Blood-pressure insensitive arterial stiffness the major cardiovascular risk factor in ESRD (Video MP4 Format)
Symposium 8.1 New Concepts In Cardiovascular Disease In CKD Patients – The role of endothelial glycocalyx in health and disease (Video MP4 Format)
Symposium 8.1 New Concepts In Cardiovascular Disease In CKD Patients – Treatment of atrial fibrillation in patients with CKD a way between Scylla and Charybdis (Video MP4 Format)
Symposium 8.2 Diabetic nephropathy in 2021 – Beyond antidiabetic drugs for DKD what is new and upcoming (Video MP4 Format)
Symposium 8.2 Diabetic nephropathy in 2021 – How should future trials for DKD look like (Video MP4 Format)
Symposium 8.2 Diabetic nephropathy in 2021 – Nephroprotective antidiabetic drugs a prescription algorithm (Video MP4 Format)
Symposium 8.3 Hypertension treatment in special renal populations – Hypertension in children and adolescents in CKD (Video MP4 Format)
Symposium 8.3 Hypertension treatment in special renal populations – Hypertension in patients with renal transplantation current concepts and future directions (Video MP4 Format)
Symposium 8.3 Hypertension treatment in special renal populations – Hypertension management in transition from CKD to ESRD (Video MP4 Format)
Symposium 8.4 Kdigo Clinical Practice Guideline On Diabetes Management In CKD – HbA1c and beyond (Video MP4 Format)
Symposium 8.4 Kdigo Clinical Practice Guideline On Diabetes Management In CKD – Organ protection the new concept (Video MP4 Format)
Symposium 8.4 Kdigo Clinical Practice Guideline On Diabetes Management In CKD – Standard-of-care and self-management (Video MP4 Format)
Symposium 9.1 AKI In Special Situations – AKI a true risk or predictor of CKD (Video MP4 Format)
Symposium 9.1 AKI In Special Situations – AKI in oncology patients (Video MP4 Format)
Symposium 9.1 AKI In Special Situations – COVID-19 and AKI (Video MP4 Format)
Symposium 9.2 What Progress In AKI – AKI alerting systems, AI, biomarkers and imaging (Video MP4 Format)
Symposium 9.2 What Progress In AKI – AKI long-term consequences (Video MP4 Format)
Symposium 9.2 What Progress In AKI – AKI repair or regeneration what to target, when and how (Video MP4 Format)
Symposium 9.3 Endocannabinoids And Kidney – Cannabinoid receptor and hepatorenal syndrome (Video MP4 Format)
Symposium 9.3 Endocannabinoids And Kidney – From the endocannabinoid system to the endocannabinoidome (Video MP4 Format)
Symposium 9.3 Endocannabinoids And Kidney – The role of cannabinoid signalling in chronic kidney diseases (Video MP4 Format)
Symposium 9.4 New aspects in AKI prevention and treatment – ‘Subclinical’ AKI – does it matter (Video MP4 Format)
Symposium 9.4 New aspects in AKI prevention and treatment – Cost-effective prevention strategies for AKI (Video MP4 Format)
Symposium 9.4 New aspects in AKI prevention and treatment – New treatment options for AKI – does anything work (Video MP4 Format)
The Virus And The Kidney – ACID BASE DISORDERS IN COVID-19 (Video MP4 Format)
The Virus And The Kidney – COVID-19 IMPACT ON ELDERLY HEMODIALYSIS POPULATION RESULTS FROM THE SPANISH (Video MP4 Format)
The Virus And The Kidney – COVID-19 IN PATIENTS ON KIDNEY REPLACEMENT THERAPY – CLINICAL CHARACTERISTICS (Video MP4 Format)
The Virus And The Kidney – COVID-19 RELATED MORTALITY IN KIDNEY TRANSPLANT AND DIALYSIS PATIENTS. A COMPARATIVE (Video MP4 Format)
The Virus And The Kidney – New data on transcriptomics and proteomics of COVID 19 in the kidney (Video MP4 Format)
Transplantation & New Technologies – Comprehensive Conservative Care what doctors say, what patients hear (Video MP4 Format)
Transplantation & New Technologies – Kidney allograft fibrosis what we have learned from latest translational research studies (Video MP4 Format)
Transplantation & New Technologies – MAGNETIC RESONANCE IMAGING TEXTURE ANALYSIS PREDICTS INTERSTITIAL FIBROSIS (Video MP4 Format)
Transplantation & New Technologies – SURVIVAL BENEFIT OF KIDNEY TRANSPLANTATION COMPARED TO REMAINING (Video MP4 Format)
Transplantation & New Technologies – THE UPTAKE OF PET RADIOTRACER 18 F-FLUORODEOXYGLUCOSE BY THE RENAL ALLOGRAFT (Video MP4 Format)
Transplantation Risk & Complications – BONE DENSITOMETRY IN RENAL TRANSPLANTED PATIENTS (Video MP4 Format)
Transplantation Risk & Complications – DIURETIC USE IS ASSOCIATED WITH INCREASED RISK FOR POSTTRANSPLANTATION DIABETES (Video MP4 Format)
Transplantation Risk & Complications – Kidney transplant suitability for patients with prior cancers what the nephrologist should know (Video MP4 Format)
Transplantation Risk & Complications – PATTERNS OF RENAL OSTEODYSTROPHY ONE YEAR AFTER KIDNEY TRANSPLANTATION (Video MP4 Format)
Transplantation Risk & Complications – RENAL TRANSPLANTATION MITIGATES INCREASED BIOLOGICAL (EPIGENETIC) AGE IN CHRONIC KIDNEY DISEASE (Video MP4 Format)
Transplantation Short- And Long-Term Outcomes – CHANGES IN PERIPHERAL NK CELLS IN KIDNEY TRANSPLANT RECIPIENTS (Video MP4 Format)
Transplantation Short- And Long-Term Outcomes – IMPACT OF POLYCLONAL ANTI-T-LYMPHOCYTE IMMUNOGLOBULINS ON THE RECURRENCE (Video MP4 Format)
Transplantation Short- And Long-Term Outcomes – NON-HLA ANTIBODIES AND EPLET MISMATCHES IN KIDNEY TRANSPLANT RECIPIENTS (Video MP4 Format)
Transplantation Short- And Long-Term Outcomes – Recurrent glomerulonephritis after kidney transplantation an update (Video MP4 Format)
Transplantation Short- And Long-Term Outcomes – SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2I) SHORT-TERM OUTCOME (Video MP4 Format)
Treat Diabetes – EFFECT OF GEMIGLIPTIN ON BIOMARKERS OF KIDNEY INJURY AND VASCULAR CALCIFICATION (Video MP4 Format)
Treat Diabetes – EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR EVENTS BY BASELINE ALBUMINURIA (Video MP4 Format)
Treat Diabetes – EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS (Video MP4 Format)
Treat Diabetes – Renal histology in patients with type 2 diabetes the hidden role of vascular damage (Video MP4 Format)
Treat Diabetes – URINARY CCL5 MRNA, A POTENTIAL BIOMARKER FOR PROGRESSION OF TYPE 2 DIABETIC NEPHROPATHY (Video MP4 Format)
Treatment & Outcome Of Glomerulonephritis – C3 Glomerulopathy and Membranoproliferative Glomerulonephritis different diseases same treatment (Video MP4 Format)
Treatment & Outcome Of Glomerulonephritis – CRESCENTS DERIVE FROM SINGLE PODOCYTE PROGENITORS AND A DRUG ENHANCING (Video MP4 Format)
Treatment & Outcome Of Glomerulonephritis – INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY (Video MP4 Format)
Treatment & Outcome Of Glomerulonephritis – NEUTROPHILS PLAY A KEY ROLE ON THE INITIATION OF GLOMERULAR HEMATURIA IN A POSTINFECTIOUS (Video MP4 Format)
Treatment & Outcome Of Glomerulonephritis – RENAL OUTCOME AFTER RITUXIMAB IN ADULT-ONSET IGA VASCULITIS AND CRESCENTIC IGA NEPHROPATHY (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 1 (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 2 (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 3 (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 4 (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 5 (Video MP4 Format)
WELCOME CEREMONY + WELCOME LECTURE 6 (Video MP4 Format)